Category: BioTech

Analysis, BioTech, Commodities, Consumer Goods, Diversified Tech, Finance, Financial, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Tourmaline Posts Impressive Quarter Despite Challenges

Tourmaline Oil reported second-quarter results after the market closed on Friday. Despite weatherrelated setbacks, the company still increased production, and has now set the stage to deliver phenomenal growth in the second half of the year. Results for the quarter lined up with expectations. Production averaged 70.1 thousand barrels of oil equivalent per day versus our forecast of 70.9 mboe/d. Earnings per share was spot-on … Continue reading Tourmaline Posts Impressive Quarter Despite Challenges

John MeadyLeave a comment
Biotechnology Stockmarket Biotech
BioTech, Finance

Sunesis Pharmaceuticals Stock Down : Biotech Trial Failure

Shares of Sunesis Pharmaceuticals, Inc (SNSS) plunged significantly after the company announced that its phase III trial, VALOR, failed to meet its primary endpoint. The randomized, double-blind, placebo-controlled trial (n=711) evaluated the efficacy of Qinprezo (vosaroxin) and cytarabine in patients suffering from first relapsed or refractory acute myeloid leukemia (AML). The trial failed to reach its primary endpoint of a statistically significant improvement in overall … Continue reading Sunesis Pharmaceuticals Stock Down : Biotech Trial Failure

Richard Atkins
Analysis, BioTech, Commodities, Consumer Goods, Diversified Tech, Finance, Financial, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Second Quarter Profits Rise for STI

Second-quarter profits to common investors at SunTrust Banks rose 35% to $365 million, or $0.68 a diluted share, from $270 million, or $0.50 a diluted share, a year earlier. Net interest income fell 5% to about $1.2 billion, as reported net interest margin fell to 3.25% from 3.39% in 2012’s second quarter. However, SunTrust’s earnings were helped by reduced loan-loss provisioning, which dropped to $146 … Continue reading Second Quarter Profits Rise for STI

Kristen BartonLeave a comment
Analysis, BioTech, Commodities, Consumer Goods, Diversified Tech, Finance, Financial, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

COF Sailing Along Into Q3

Capital One Financial Corporation reported net income of $1.1 billion or $1.87 per diluted share in the second quarter of 2013, compared with $1.0 billion or $1.79 per diluted share last quarter, and $92 million in second-quarter 2012. Last year’s results reflected significant purchase accounting impacts as Capital One closed the acquisition of HSBC U.S. card business. The largest impact was the larger loan loss … Continue reading COF Sailing Along Into Q3

Mark DeFranceLeave a comment
PRAN NASDAQ PRAN Prana Biotechnology
BioTech, Finance

Biotech Stocks: A Look At the Most Promising Biotech Stocks

The oft-trodden path for a startup biotech is to aim for either a buyout or an IPO—or at minimum, a partnership with a big pharmaceutical company—before dealing with the hefty price tag of a Phase 3 study. One local biotech, however, took on the risk of bucking that trend—and succeeded. That story and much more below. Boston and Hayward, CA-based Intarcia turned heads earlier this … Continue reading Biotech Stocks: A Look At the Most Promising Biotech Stocks

Richard Atkins
Analysis, BioTech, Commodities, Consumer Goods, Diversified Tech, Finance, Financial, Mergers & Acquisitions, Semiconductors, Services Sector, Software, Tech IPO, Venture Capital

Melco Crown Reports Robust Earnings in Second Quarter

Melco Crown Entertainment announced solid second quarter results that were above analysts expectations and consensus estimates. Revenue increased 38% to $1.3 billion (above consensus of $1.2 billion) and adjusted EBITDA increased 62% to $330 million (well above consensus of $283 million), as the company’s City of Dreams casino on the Cotai Strip continued to take share from casinos on the Macau peninsula. Adjusted EBITDA margins … Continue reading Melco Crown Reports Robust Earnings in Second Quarter

Adam KeintzelLeave a comment